The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have demonstrated that mutation of RKIP at the PKC phosphorylation site to S153A prevents RKIP from improving cardiac contractility and increases cardiomyocyte death and collagen deposition (31).”
From Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop (2022) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Molecular basis of physiological heart growth: fundamental concepts and new players
Maillet, M., van Berlo, J. H., & Molkentin, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3495 · Cited by 536
Pleger, S. T., Shan, C., Ksienzyk, J., Bekeredjian, R., Boekstegers, P., Hinkel, R., Schinkel, S., Leuchs, B., Ludwig, J., Qiu, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002097 · Cited by 234
Self-citationThe enhanced contractility of the phospholamban-deficient mouse heart persists with aging
Slack, J. P., Grupp, I. L., Dash, R., Holder, D., Schmidt, A., Gerst, M. J., Tamura, T., Tilgmann, C., James, P. F., Johnson, R., et al. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1370 · Cited by 64
Research works printed but not linked: 66
- McMurray, J.J.V. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33, 1787–1847 (2012). · DOI · Paper page
- Tacon, C.L., McCaffrey, J. & Delaney, A. Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials. Intensive Care Med. 38, 359–367 (2012). · DOI · Paper page
- Engelhardt, S., Hein, L., Wiesmann, F. & Lohse, M.J. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. USA 96, 7059–7064 (1999). · DOI · Paper page
- Communal, C., Singh, K., Sawyer, D.B. & Colucci, W.S. Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin–sensitive G protein. Circulation 100, 2210–2212 (1999). · DOI · Paper page
- Liggett, S.B. et al. Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101, 1707–1714 (2000). · DOI · Paper page
- Rockman, H.A., Koch, W.J. & Lefkowitz, R.J. Seven-transmembrane-spanning receptors and heart function. Nature 415, 206–212 (2002). · DOI · Paper page
- Xiao, R.-P. β-adrenergic signaling in the heart: dual coupling of the β2-adrenergic receptor to Gs and Gi proteins. Sci. STKE 2001, re15 (2001).
- Ahmet, I. et al. Cardioprotective and survival benefits of long-term combined therapy with β2-adrenoreceptor (AR) agonist and β1-AR blocker in dilated cardiomyopathy postmyocardial infarction. J. Pharmacol. Exp. Ther. 325, 491–499 (2008). · DOI
- Raake, P.W. et al. G protein–coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ. Res. 103, 413–422 (2008). · DOI
- Raake, P.W. et al. Cardiac G protein–coupled receptor kinase 2 ablation induces a novel Ca2+-handling phenotype resistant to adverse alterations and remodeling after myocardial infarction. Circulation 125, 2108–2118 (2012). · DOI
- Völkers, M. et al. The inotropic peptide β−ARKct improves AR responsiveness in normal and failing cardiomyocytes through Gβγ-mediated L-type calcium current disinhibition. Circ. Res. 108, 27–39 (2011). · doi:10.1161/circresaha.110.225201
- Fu, X., Koller, S., Abd Alla, J. & Quitterer, U. Inhibition of G protein–coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway. J. Biol. Chem. 288, 7738–7755 (2013). · DOI
- Kairouz, V., Lipskaia, L., Hajjar, R.J. & Chemaly, E.R. Molecular targets in heart failure gene therapy: current controversies and translational perspectives. Ann. NY Acad. Sci. 1254, 42–50 (2012). · DOI · Paper page
- Matkovich, S.J. et al. Cardiac-specific ablation of G protein receptor kinase 2 redefines its roles in heart development and β-adrenergic signaling. Circ. Res. 99, 996–1003 (2006). · DOI · Paper page
- Lorenz, K., Lohse, M.J. & Quitterer, U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426, 574–579 (2003). · DOI · Paper page
- Yeung, K. et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173–177 (1999). · DOI · Paper page
- Deiss, K., Kisker, C., Lohse, M.J. & Lorenz, K. Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein–coupled receptor kinase (GRK) 2. J. Biol. Chem. 287, 23407–23417 (2012). · DOI
- Corbit, K.C. et al. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J. Biol. Chem. 278, 13061–13068 (2003). · DOI · Paper page
- Palczewski, K., Buczyłko, J., Lebioda, L., Crabb, J.W. & Polans, A.S. Identification of the N-terminal region in rhodopsin kinase involved in its interaction with rhodopsin. J. Biol. Chem. 268, 6004–6013 (1993). · DOI
- Lorenz, K., Schmitt, J.P., Schmitteckert, E.M. & Lohse, M.J. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat. Med. 15, 75–83 (2009). · DOI · Paper page
- Ruppert, C. et al. Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 110, 7440–7445 (2013). · DOI
- Braz, J.C. et al. PKC-α regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248–254 (2004). · DOI · Paper page
- Hambleton, M. et al. Pharmacological- and gene therapy–based inhibition of protein kinase Cα/β enhances cardiac contractility and attenuates heart failure. Circulation 114, 574–582 (2006). · DOI
- Dorn, G.W. et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes ɛ protein kinase C translocation. Proc. Natl. Acad. Sci. USA 96, 12798–12803 (1999). · DOI · Paper page
- Lehnart, S.E., Maier, L.S. & Hasenfuss, G. Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail. Rev. 14, 213–224 (2009). · DOI
- Rohrer, D.K., Schauble, E.H., Desai, K.H., Kobilka, B.K. & Bernstein, D. Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse. Am. J. Physiol. 274, H1184–H1193 (1998).
- Chruscinski, A.J. et al. Targeted disruption of the β2-adrenergic receptor gene. J. Biol. Chem. 274, 16694–16700 (1999). · DOI · Paper page
- Ling, H. et al. Requirement for Ca2+/calmodulin–dependent kinase II in the transition from pressure overload–induced cardiac hypertrophy to heart failure in mice. J. Clin. Invest. 119, 1230–1240 (2009). · DOI · Paper page
- Shiferaw, Y., Aistrup, G.L. & Wasserstrom, J.A. Intracellular Ca2+ waves, afterdepolarizations and triggered arrhythmias. Cardiovasc. Res. 95, 265–268 (2012). · DOI
- Guo, T., Zhang, T., Mestril, R. & Bers, D.M. Ca2+/calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ. Res. 99, 398–406 (2006). · DOI · Paper page
- Bers, D.M. Ryanodine receptor S2808 phosphorylation in heart failure: smoking gun or red herring. Circ. Res. 110, 796–799 (2012). · doi:10.1161/circresaha.112.265579
- Eschenhagen, T. Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure? J. Clin. Invest. 120, 4197–4203 (2010). · doi:10.1172/jci45251
- Respress, J.L. et al. Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ. Res. 110, 1474–1483 (2012). · DOI · Paper page
- Dobrev, D. & Wehrens, X.H.T. Role of RyR2 phosphorylation in heart failure and arrhythmias: controversies around ryanodine receptor phosphorylation in cardiac disease. Circ. Res. 114, 1311–1319 (2014). · DOI · Paper page
- Shan, J. et al. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J. Clin. Invest. 120, 4388–4398 (2010). · DOI · Paper page
- Anderson, M.E., Brown, J.H. & Bers, D.M. CaMKII in myocardial hypertrophy and heart failure. J. Mol. Cell. Cardiol. 51, 468–473 (2011). · DOI · Paper page
- Huke, S. & Bers, D.M. Ryanodine receptor phosphorylation at serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 376, 80–85 (2008). · DOI
- Orchard, C. & Brette, F. T-tubules and sarcoplasmic reticulum function in cardiac ventricular myocytes. Cardiovasc. Res. 77, 237–244 (2008). · DOI
- Nikolaev, V.O. et al. β2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327, 1653–1657 (2010). · DOI · Paper page
- Kuschel, M. et al. Gi protein–mediated functional compartmentalization of cardiac β2-adrenergic signaling. J. Biol. Chem. 274, 22048–22052 (1999). · DOI · Paper page
- Xiao, R.P. et al. Coupling of β2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ. Res. 84, 43–52 (1999). · DOI · Paper page
- Daaka, Y., Luttrell, L.M. & Lefkowitz, R.J. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature 390, 88–91 (1997). · DOI · Paper page
- Talan, M.I., Ahmet, I., Xiao, R.-P. & Lakatta, E.G. β2-AR agonists in treatment of chronic heart failure: long path to translation. J. Mol. Cell. Cardiol. 51, 529–533 (2011). · DOI
- Chesley, A. et al. The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3′ kinase. Circ. Res. 87, 1172–1179 (2000). · DOI · Paper page
- Kranias, E.G. & Hajjar, R.J. Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome. Circ. Res. 110, 1646–1660 (2012). · DOI · Paper page
- Greenberg, B. et al. Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure. JACC: Heart Failure 2, 84–92 (2014).
- Antos, C.L. et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ. Res. 89, 997–1004 (2001). · DOI · Paper page
- El-Armouche, A. et al. Phosphatase inhibitor-1–deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc. Res. 80, 396–406 (2008). · DOI
- Koval, O.M. et al. CaV1.2 β-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations. Proc. Natl. Acad. Sci. USA 107, 4996–5000 (2010). · DOI
- Rohrer, D.K. et al. Targeted disruption of the mouse β1-adrenergic receptor gene: developmental and cardiovascular effects. Proc. Natl. Acad. Sci. USA 93, 7375–7380 (1996). · DOI · Paper page
- Rohrer, D.K., Chruscinski, A., Schauble, E.H., Bernstein, D. & Kobilka, B.K. Cardiovascular and metabolic alterations in mice lacking both β1- and β2-adrenergic receptors. J. Biol. Chem. 274, 16701–16708 (1999). · DOI · Paper page
- Vidal, M., Wieland, T., Lohse, M.J. & Lorenz, K. β-adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway. Cardiovasc. Res. 96, 255–264 (2012). · DOI
- Lorenz, K., Stathopoulou, K., Schmid, E., Eder, P. & Cuello, F. Heart failure–specific changes in protein kinase signalling. Pflugers Arch. 466, 1151–1162 (2014). · DOI
- Liggett, S.B. et al. The Ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J. Clin. Invest. 102, 1534–1539 (1998). · DOI · Paper page
- Siedlecka, U. et al. Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 295, H1917–H1926 (2008). · DOI
- Paur, H. et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 126, 697–706 (2012). · DOI · Paper page
- Shao, Y. et al. Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy. Int. J. Cardiol. 168, 1943–1950 (2013). · doi:10.1016/j.ijcard.2012.12.092
- Grueter, C.E., Abiria, S.A., Wu, Y., Anderson, M.E. & Colbran, R.J. Differential regulated interactions of calcium/calmodulin-dependent protein kinase ii with isoforms of voltage-gated calcium channel β subunits. Biochemistry 47, 1760–1767 (2008). · DOI
- El-Armouche, A., Pamminger, T., Ditz, D., Zolk, O. & Eschenhagen, T. Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc. Res. 61, 87–93 (2004). · DOI
- Ruiz-Gómez, A. et al. Phosphorylation of phosducin and phosducin-like protein by G protein–coupled receptor kinase 2. J. Biol. Chem. 275, 29724–29730 (2000). · doi:10.1074/jbc.m001864200
- Nakayama, H. et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest. 117, 2431–2444 (2007). · DOI · Paper page
- Schultz, J.E., Hsu, A.K., Barbieri, J.T., Li, P.L. & Gross, G.J. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am. J. Physiol. 275, H495–H500 (1998).
- Oostendorp, J. & Kaumann, A.J. Pertussis toxin suppresses carbachol-evoked cardiodepression but does not modify cardiostimulation mediated through β1- and putative β4-adrenoceptors in mouse left atria: no evidence for β2- and β3-adrenoceptor function. Naunyn Schmiedebergs Arch. Pharmacol. 361, 134–145 (2000). · DOI
- Braz, J.C., Bueno, O.E., De Windt, L.J. & Molkentin, J.D. PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal–regulated kinase 1/2 (ERK1/2). J. Cell Biol. 156, 905–919 (2002). · DOI · Paper page
- Picht, E., Zima, A.V., Blatter, L.A. & Bers, D.M. SparkMaster: automated calcium spark analysis with ImageJ. Am. J. Physiol. Cell Physiol. 293, C1073–C1081 (2007). · DOI · Paper page
- Barry, P.H. JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J. Neurosci. Methods 51, 107–116 (1994). · DOI · Paper page
Cited by
Lee, J., Olivieri, C., Ong, C., Masterson, L. R., Gomes, S., Lee, B.-S., Schaefer, F., Lorenz, K., Veglia, G., & Rosner, M. R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121867119 · Cited by 20
Self-citation
Metadata
- Authors
- Schmid, E., Neef, S., Berlin, C., Tomasovic, A., Kahlert, K., Nordbeck, P., Deiss, K., Denzinger, S., Herrmann, S., Wettwer, E., Weidendorfer, M., Becker, D., Schäfer, F., Wagner, N., Ergün, S., Schmitt, J. P., Katus, H. A., Weidemann, F., Ravens, U., Maack, C., Hein, L., Ertl, G., Müller, O. J., Maier, L. S., Lohse, M. J., & Lorenz, K.
- Venue
- Nature Medicine
- Published
- 2015-10-19
- Volume
- 21
- Issue
- 11
- Pages
- 1298-1306
- ISSN
- 1078-8956
- 1546-170X
- Cited by
- 65
- References
- 4
- Language
- en
- Update notices
- erratum (2016-02-04)
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy. https://app.cochat.ai/papers/10.1038/nm.3972
- The paper
- Schmid, E., Neef, S., Berlin, C., Tomasovic, A., Kahlert, K., Nordbeck, P., Deiss, K., Denzinger, S., Herrmann, S., Wettwer, E., Weidendorfer, M., Becker, D., Schäfer, F., Wagner, N., Ergün, S., Schmitt, J. P., Katus, H. A., Weidemann, F., Ravens, U., . . . Lorenz, K. (2015). Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy. Nature Medicine. https://doi.org/10.1038/nm.3972
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.